RHAPSIDO
LIVE

Serial Number

98828714

Owner

Novartis AG

Attorney

Maury M. Tepper, III

Filing Date

Oct 30, 2024

Add to watchlist:

No watchlists yet
View on USPTO

RHAPSIDO Trademark

Serial Number: 98828714

RHAPSIDO is a trademark filed by Novartis AG on October 30, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Novartis AG (13 trademarks)

CH-4002 Basel

Entity Type: 03

Trademark Details

Filing Date

October 30, 2024

Registration Date

Not Registered

Published for Opposition

June 17, 2025

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

ITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST
Jun 29, 2026 INCE
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 18, 2026 AITU
SOU TEAS EXTENSION RECEIVED
Feb 10, 2026 EEXT
TEAS STATEMENT OF USE RECEIVED
Oct 24, 2025 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 12, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 17, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jun 17, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 11, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 14, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 9, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 9, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 9, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 1, 2025 GNRN
NON-FINAL ACTION E-MAILED
May 1, 2025 GNRT
NON-FINAL ACTION WRITTEN
May 1, 2025 CNRT
ASSIGNED TO EXAMINER
Apr 30, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 25, 2025 NWOS
NEW APPLICATION ENTERED
Oct 30, 2024 NWAP